Who
Kenneth A. Clark
Director
Company insider
Files Form 4 as: Director, Summit Therapeutics; Director, Pulse Biosciences; Director, Pharmacyclics.
In numbers
- Trades disclosed
- 49
- Buys
- 0
- Sells
- 0
- Bought
- $0
- Sold
- $0
- Companies
- 3
- Companies where not an officer
- 3
- First trade
- 9 Nov 2012
- Last trade
- 2 Jan 2026
- Last filed
- 6 Jan 2026
Companies traded
Activity over time
Not enough dated trades to draw.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 2 Jan 2026filed 6 Jan 2026 | SMMT Summit Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —35,000 | filing |
| 2 Jan 2026filed 6 Jan 2026 | SMMT Summit Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | $156K17,796 at $8.76 | filing |
| 2 Jan 2026filed 6 Jan 2026 | SMMT Summit Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —35,000 | filing |
| 2 Jan 2026filed 6 Jan 2026 | SMMT Summit Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | $156K17,796 at $8.76 | filing |
| 2 Jan 2025filed 6 Jan 2025 | SMMT Summit Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —35,000 | filing |
| 2 Jan 2025filed 6 Jan 2025 | SMMT Summit Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | $156K16,991 at $9.18 | filing |
| 11 Oct 2024filed 15 Oct 2024 | SMMT Summit Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —200,000 | filing |
| 2 Jan 2024filed 4 Jan 2024 | SMMT Summit Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —35,000 | filing |
| 2 Jan 2024filed 4 Jan 2024 | SMMT Summit Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | $93K70,492 at $1.32 | filing |
| 3 Jan 2023filed 5 Jan 2023 | SMMT Summit Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —35,000 | filing |
| 3 Jan 2023filed 5 Jan 2023 | SMMT Summit Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | $74K44,400 at $1.67 | filing |
| 3 Jan 2022filed 5 Jan 2022 | SMMT Summit Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —25,000 | filing |
| 3 Jan 2022filed 5 Jan 2022 | SMMT Summit Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | $66K58,510 at $1.13 | filing |
| 7 Oct 2021filed 12 Oct 2021 | SMMT Summit Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —200,000 | filing |
| 7 Oct 2021filed 12 Oct 2021 | SMMT Summit Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —6,250 | filing |
| 20 May 2021filed 21 May 2021 | PLSE Pulse Biosciencesoption or derivative · Medical Devices | SEC FORM 4 Code A | —20,000 at $0.00 | filing |
| 20 May 2021filed 21 May 2021 | PLSE Pulse Biosciencesoption or derivative · Medical Devices | SEC FORM 4 Code A | —8,026 at $0.00 | filing |
| 18 May 2020filed 19 May 2020 | PLSE Pulse Biosciencesoption or derivative · Medical Devices | SEC FORM 4 Code A | —20,000 at $0.00 | filing |
| 18 May 2020filed 19 May 2020 | PLSE Pulse Biosciencesoption or derivative · Medical Devices | SEC FORM 4 Code A | —14,071 at $0.00 | filing |
| 16 May 2019filed 17 May 2019 | PLSE Pulse Biosciencesoption or derivative · Medical Devices | SEC FORM 4 Code A | —15,000 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.
Sectors
No trade we could place in a sector.